Document Detail


Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.
MedLine Citation:
PMID:  10377348     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Neural cell development is regulated by membrane ion channel activity. We have previously demonstrated that cell membrane depolarization with veratridine or blockage of K+ channels with tetraethylammonium (TEA) inhibit oligodendrocyte progenitor (OP) proliferation and differentiation (); however the molecular events involved are largely unknown. Here we show that forskolin (FSK) and its derivative dideoxyforskolin (DFSK) block K+ channels in OPs and inhibit cell proliferation. The antiproliferative effects of TEA, FSK, DFSK, and veratridine were attributable to OP cell cycle arrest in G1 phase. In fact, (1) cyclin D accumulation in synchronized OP cells was not affected by K+ channel blockers or veratridine; (2) these agents prevented OP cell proliferation only if present during G1 phase; and (3) G1 blockers, such as rapamycin and deferoxamine, mimicked the anti-proliferative effects of K+ channel blockers. DFSK also prevented OP differentiation, whereas FSK had no effect. Blockage of K+ channels and membrane depolarization also caused accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in OP cells. The antiproliferative effects of K+ channel blockers and veratridine were still present in OP cells isolated from INK4a-/- mice, lacking the cyclin-dependent kinase inhibitors p16(INK4a) and p19(ARF). Our results demonstrate that blockage of K+ channels and cell depolarization induce G1 arrest in the OP cell cycle through a mechanism that may involve p27(Kip1) and p21(CIP1) and further support the conclusion that OP cell cycle arrest and differentiation are two uncoupled events.
Authors:
C A Ghiani; X Yuan; A M Eisen; P L Knutson; R A DePinho; C J McBain; V Gallo
Related Documents :
20067818 - Cellular and molecular mechanisms of bromate-induced cytotoxicity in human and rat kidn...
19492998 - Rottlerin: a multifaced regulator of keratinocyte cell cycle.
10537318 - Microinjection of anti-p21 antibodies induces senescent hs68 human fibroblasts to synth...
18378678 - The lim-only protein fhl2 regulates cyclin d1 expression and cell proliferation.
15842628 - Marking cell lineages in living tissues.
20679878 - Advancement in the examination of the human cardiac sinus node: an unexpected architect...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of neuroscience : the official journal of the Society for Neuroscience     Volume:  19     ISSN:  0270-6474     ISO Abbreviation:  J. Neurosci.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-07-15     Completed Date:  1999-07-15     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8102140     Medline TA:  J Neurosci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  5380-92     Citation Subset:  IM    
Affiliation:
Laboratory of Cellular and Molecular Neurophysiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4495, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
8-Bromo Cyclic Adenosine Monophosphate / pharmacology
Animals
Cell Cycle Proteins*
Cell Division / drug effects
Cell Lineage / drug effects
Cerebellum / drug effects
Cyclin D
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cyclins / metabolism*
Deferoxamine / pharmacology
Forskolin / analogs & derivatives,  pharmacology
Ion Channel Gating / drug effects
Isoproterenol / pharmacology
Membrane Potentials* / drug effects
Mice
Microtubule-Associated Proteins / metabolism*
Oligodendroglia / cytology*,  drug effects,  metabolism
Potassium / metabolism
Potassium Channel Blockers
Potassium Channels / physiology*
Rats
Rats, Sprague-Dawley
Sirolimus / pharmacology
Stem Cells / cytology*,  drug effects,  metabolism
Tetraethylammonium / pharmacology
Tumor Suppressor Proteins*
Veratridine / pharmacology
Chemical
Reg. No./Substance:
0/Cdkn1a protein, mouse; 0/Cdkn1a protein, rat; 0/Cdkn1b protein, mouse; 0/Cdkn1b protein, rat; 0/Cell Cycle Proteins; 0/Cyclin D; 0/Cyclin-Dependent Kinase Inhibitor p21; 0/Cyclins; 0/Microtubule-Associated Proteins; 0/Potassium Channel Blockers; 0/Potassium Channels; 0/Tumor Suppressor Proteins; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; 23583-48-4/8-Bromo Cyclic Adenosine Monophosphate; 53123-88-9/Sirolimus; 64657-18-7/1,9-dideoxyforskolin; 66-40-0/Tetraethylammonium; 66428-89-5/Forskolin; 70-51-9/Deferoxamine; 71-62-5/Veratridine; 7440-09-7/Potassium; 7683-59-2/Isoproterenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Selective disruption of "late onset" sagittal banding patterns by ectopic expression of engrailed-2 ...
Next Document:  Functionally antagonistic interactions between the TrkA and p75 neurotrophin receptors regulate symp...